Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma
Clinical trial NCT00077532 · COMPLETED
Trial details
- NCT number
- NCT00077532
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-01-01
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.